10.1007/s00125-024-06192-7 153 WalleniusV.EliasE.ElebringE.HaismaB.CasselbrantA.LarraufieP.et al (2020)
Duration: Use for 8-12 weeks followed by a washout period
Injections are particularly appropriate for those with: Pernicious anaemia, an autoimmune condition affecting B12 absorption Conditions affecting the stomach or small intestine, such as Crohns disease or coeliac disease Those who have had gastric surgery or bariatric procedures Strict vegans and vegetarians not meeting their B12 needs through food or oral supplements For those who can absorb B12 normally, oral supplements are generally an effective and well-evidenced alternative to injections
doi: 10.3389/fimmu.2020.01965 Summary Keywords systemic lupus erythematosus, chimeric antigen receptor T-cell, CD19, BCMA, therapeutic strategy, clinical implications Citation Zhou J, Lei B, Shi F, Luo X, Wu K, Xu Y, Zhang Y, Liu R, Wang H, Zhou J and He X (2024) CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives
Insulin-like growth factor long arginine 3 (IGF-1 LR3), is a widely used synthetic analog of IGF-1 with an arginine replacing glutamic acid at position 3 (arginine 3, R3), and an additional 13 amino acids at its N-terminus (long, L)
